scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1041653160 |
P356 | DOI | 10.1038/MODPATHOL.2012.142 |
P932 | PMC publication ID | 5485410 |
P698 | PubMed publication ID | 22936064 |
P5875 | ResearchGate publication ID | 230768830 |
P50 | author | L Jeffrey Medeiros | Q87358453 |
Farhad Ravandi | Q40614280 | ||
P2093 | author name string | Carlos E Bueso-Ramos | |
Tariq Muzzafar | |||
Keyur P Patel | |||
M James You | |||
Faisal A Khokhar | |||
Sherrie Pierce | |||
P2860 | cites work | Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes | Q72996073 |
A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions | Q74182230 | ||
t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia | Q80203202 | ||
Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia | Q80280736 | ||
The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts | Q33213802 | ||
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) | Q33235500 | ||
Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0). | Q33331406 | ||
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia | Q33844299 | ||
Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients | Q34266316 | ||
Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. | Q34312964 | ||
Application of COLD-PCR for improved detection of KRAS mutations in clinical samples | Q34980299 | ||
Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia | Q35779731 | ||
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase | Q36352764 | ||
Terminal deoxynucleotidyl transferase is found in prothymocytes | Q36359762 | ||
Cell cycle and developmental control of hematopoiesis by Runx1. | Q36543603 | ||
AML-MO: clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Dutch Slide Review Committee of Leukemias in Adults | Q36689418 | ||
Genome wide molecular analysis of minimally differentiated acute myeloid leukemia | Q37406787 | ||
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations | Q37427648 | ||
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status. | Q38351617 | ||
Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia | Q40489020 | ||
Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosis. | Q40983463 | ||
Oncogenic transcription factors in the human acute leukemias | Q41628889 | ||
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia | Q44654291 | ||
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. | Q46111829 | ||
Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal | Q46479272 | ||
Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia. | Q53342566 | ||
Identification of RUNX1/AML1 as a classical tumor suppressor gene | Q60589916 | ||
Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients. | Q64970930 | ||
Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) | Q72282824 | ||
P433 | issue | 2 | |
P921 | main subject | leukemia | Q29496 |
acute myeloid leukemia with minimal differentiation | Q55779855 | ||
P304 | page(s) | 195-203 | |
P577 | publication date | 2012-08-31 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation | |
P478 | volume | 26 |
Q58481761 | Acute myeloid leukemia |
Q50020680 | Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy. |
Q31165460 | Expansion of the preimmune antibody repertoire by junctional diversity in Bos taurus. |
Q91289390 | High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma |
Q49544825 | Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance |
Q38213642 | Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review |
Search more.